Janus kinase (JAK) inhibitors are a promising and new method of treating alopecia areata, giving doctors new options for ...

Maria Hordinsky, MD, discusses exciting results in alopecia areata, including some discussed at the Winter Clinical ...

Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on ...

Patients with alopecia areata (AA) who do not respond to treatment with one of the three approved JAK inhibitors may get a response by switching to one of the other JAK inhibitors, a small study has ...

The MarketWatch News Department was not involved in the creation of this content. DOVER, Del., Nov. 6, 2025 /PRNewswire/ -- Eilean Therapeutics LLC, a biotechnology company developing next-generation ...

Add Yahoo as a preferred source to see more of our stories on Google. Lynk Pharmaceuticals' next generation JAK inhibitor Lynk Pharmaceuticals has posted positive topline results from a Phase III ...

Among patients with AD, receipt of JAK inhibitors was associated with an increased risk for acne compared with Th2 cytokine inhibitors.

Please provide your email address to receive an email when new articles are posted on . Understanding of the safety and efficacy of JAK inhibitors continues to evolve. Real-world data sheds light on ...

Please provide your email address to receive an email when new articles are posted on . The 6-month risk of acne was higher among those receiving a JAK inhibitor vs. a Th2 cytokine inhibitor (4.93% vs ...

Existing autoimmune drugs may prevent or reverse a serious side effect faced by patients with cancer. Immunotherapy-induced type 1 diabetes is a serious side effect faced by some patients receiving ...

(MENAFN- EIN Presswire) EINPresswire/ -- The janus kinase (JAK) 3 inhibitor market has been witnessing significant growth recently, driven by advancements in medical research and an increasing focus ...